Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MAPK10 antisense RNA 1 (MAPK10-AS1) is a long non-coding RNA believed to be involved in the regulation of its sense gene, MAPK10, but its detailed functional biology remains poorly characterized. It is classified as an lncRNA, sourced from the antisense strand at the MAPK10 locus on chromosome 4. There is currently no evidence that MAPK10-AS1 serves as a direct therapeutic target (receptor, enzyme, transporter, etc.). Most available resources solely characterize it as an RNA gene/lncRNA, with no associated protein-coding function or recognized small molecule pharmacology[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MAPK10 antisense RNA 1 (MAPK10-AS1).